Your prediction
Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
| Protara Therapeutics Inc. | -0.820% | -2.814% | -4.783% | 28.182% | -24.126% | 51.071% | -47.125% |
| India Globalization Capital | 0.000% | 1.905% | -10.833% | -22.464% | -10.084% | -26.712% | -85.580% |
| Gensight Biologics SA | -16.240% | -17.500% | -17.500% | -54.103% | -41.799% | -84.154% | -99.093% |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat